When will we tackle Big Food like we did Big Tobacco?
Junk food is addictive and drugs like Ozempic treat addiction, but do we need to take a bigger approach to dealing with the issue, asks Australian researcher and GP Natasha Yates.
Since Ozempic hit the public consciousness as a weight-loss medication, one in eight Americans have tried it (or a version of it) to lose weight.
This is remarkable: less than five years ago, most people reading this would not have known these drugs existed. As availability of Ozempic and other GLP-1 based medications has increased, so has controversy. Are they worsening 'fat stigma'? Are they safe in the long term? Why aren't they more affordable? Aren't they just a chemical solution to a man-made problem?
When the former head of the United States Food and Drug Administration (FDA), Dr David A. Kessler, suggests answers to these questions, it is worth pausing to listen. As a GP who regularly treats patients with obesity, I found many of his arguments convincing. In Diet, Drugs and Dopamine, he writes:
"We can now effectively treat obesity [with GLP-1 injectables], even if we are only masking the root cause. It may seem absurd to have one industry make us sick only to have another industry develop drugs to treat that sickness."
Provocatively, he directly likens the smoking industry of the past to today's food industry: specifically, ultra-formulated foods, which are foods with 'super-normal combinations of fat and sugar, fat and salt, and carbs and salt, that are always within reach'. These foods have been modified from their original form to such an extent they are barely recognisable, but highly palatable and easily transportable.
Kessler speaks not only with the authority of decades of scientific understanding, but with the empathy of personal understanding: he struggles with obesity himself and used GLP-1 drugs to cut his body fat in half: from 30% to 15%.
He told the Washington Post the side effects were unpleasant, including bloating, intense chills and 'occasional sharp abdominal pains'. He also said these drugs could 'halt the trajectory of chronic disease in the United States if used under medical supervision and by the right people'.
This book deep dives into why Kessler personally, along with millions around the world, struggles to lose weight and keep it off. He points out: "I have two advanced degrees […] I have been Dean of two medical schools. I've run the FDA. No-one would ever accuse me of not having discipline and determination."
If managing weight were simply about sufficient education and willpower, Kessler – for one – would not struggle with it. But he does. His book invites readers to lay down their assumptions and be open to new ways of thinking about obesity.
He is not presenting anything new. His unique contribution here is the drawing together of insights from various fields of research (addiction, endocrinology, obesity medicine), telling a compelling story about why obesity is so prevalent and difficult to treat. It is a story of many influences: including biology, psychology and even the economy.
In some ways, this is a dense read. Kessler's references (at the end) take up a full third of the book. But in other ways, it's an easy read. He writes in a narrative style, weaving conversations with researchers into his personal story of struggle. In this way, he pre-empts reader arguments, showing us how his views differ from others.
For example, he gives voice to the opinions of the 'Body Positivity' movement – which advocates for respect and acceptance of all body sizes – while still concluding losing weight is something we need to aim for. He recognises weight is not a cosmetic issue, but a health issue: many serious diseases, like heart failure, stroke, rheumatioid arthritis and diabetes, share obesity as a risk factor.
Our society's failure to act on obesity will lead to increasing illness, Kessler argues. He backs this – and all his claims – with pages of data, which he presents in relatable forms. For example, 13 types of cancer have an increased risk with obesity. A man with a BMI greater than 40 gets nine years shaved off his life.
Kessler structures the book in four parts. The first, provocatively, is about the addictive power of food. This way of viewing food underpins the rest of the book. Part 2 explains the complex biology of weight gain and loss. (Spoiler: it's not just about counting calories and exercising.) Part 3 outlines the role of GLP-1 medications in sustainable weight loss in a comprehensive, practical and nuanced way.
And the final part cautions readers not to rely purely on medication, pointing to environmental factors that have led to obesity in the first place, like sedentary lifestyles and diets dominated by unhealthy foods.
Humming throughout, rising to a crescendo in the last section, is the accusation of a prime mover behind the obesity epidemic: hyper-palatable foods that have been created this way on purpose by adding sugar, salt and fat. This results in both long shelf lives, and enjoyable sensations when eaten (for example: crunchy or soft). Creating these properties means significantly changing a food from its original state, or even creating it from scratch in a laboratory.
He wisely refuses to get dragged into discussing 'ultra-processed foods' (UPFs), which have become a politically contentious topic. Debate around the exact definition of a 'UPF' has allowed the food industry to distract and deflect from their potential harms. By using the term 'ultra-formulated food', Kessler neatly side-steps those with a vested interest in defending UPFs.
The problem, he contends, lies in the addictive qualities of ultra-formulated foods, which – coupled with diminished nutrient content – cause metabolic mayhem when we eat them. Our glucose levels spike and visceral fat builds up.
Ultra-formulated foods are abundant, too. There are reasonable arguments that processing food has been essential in staving off starvation. But instead of helping us avoid illness, ultra-formulated products are 'weapons against our biology'.
The FDA, his prior workplace, sets guidelines around food safety, he points out. But, he asks, why there are no regulations protecting the community from food that is heavily processed to become hyper-palatable and energy dense, but low in nutrition?
Kessler's final call is directed at both individuals and communities. He calls on us to untangle ourselves from dependence on ultra-formulated foods. And he wants communities to collectively demand a healthier future.
Kessler is methodical in his explanations, continually anticipating and rebutting potential arguments. Much of what he says is compelling – but the real question is what each of us chooses to do about it.
His take-homes in a nutshell: ultra-formulated foods are addictive. GLP-1 injectables treat that addiction. But the ultimate solution is to regulate ultra-formulated foods in the first place.
Author: Natasha Yates, General Practitioner, PhD Candidate, Bond University
This article is republished from The Conversation under a Creative Commons licence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
an hour ago
- Otago Daily Times
Living life to the fullest after beating all the odds
Phoebe Finlay looks pretty good for someone who has died several times. And if she was an adult at the time, the 17-year-old said it might have scarred her for life. She was born prematurely at Dunedin Hospital at just 25 weeks and was just a little bit bigger than a pound of butter. She was so premature doctors gave her "zero chance" of survival. Her parents Ian and the late Katrina Finlay were told to prepare for the worst. She was in the neonatal intensive care unit at Dunedin Hospital for four weeks, and it is only by sheer luck that she is around today to talk about her life. Her heart, stomach and bowel had not developed enough to cope with living outside the womb and she needed major microsurgeries to keep her alive. One of the most important surgeries needed was on her stomach, because she was still too premature to digest nutrients. Unfortunately, Dunedin Hospital did not have a suitable surgeon to do it. By luck, there was a surgery conference in Dunedin on the day Phoebe was born, and one of the microsurgeons speaking at the conference was able to do the surgery. Mr Finlay said it saved his daughter's life. "She had a lot of operations, but she just kept waking up. "She's a real fighter." It was the first of several major microsurgeries before she was flown to Christchurch to see if doctors there could help with her vision problems. On the way to Dunedin Airport, the ambulance stopped twice because she died on the way, and they managed to bring her back. And when she turned up at Christchurch Hospital, doctors were amazed she was still alive. After 130 days in hospital in Dunedin and Christchurch, three months on life support, five major operations and 75 blood transfusions, Phoebe was back at Dunedin Hospital at the weekend, to visit staff and parents at the neonatal intensive care unit. "I'm visiting to see the doctors and nurses that saved my life. "They saw how sick I was, and I've come back here to show the staff how well I'm doing. "I also want to talk to other mums and dads with premature babies, and say 'don't give up hope, because I'm living proof that what they do here can get you through — just hang in there'." Phoebe and her dad live in Brisbane these days, but she fiercely clings to her Kiwi identity. Despite her continued vision impairment, Phoebe's main passion in life is sport — particularly triathlon and tennis. "When I play tennis, the ball has got like this rattle in it, and I hear that. "You get three bounces to hit the ball." She is in the top three blind/low-vision players in Australian women's tennis. She also recently came fourth in the Australian National Paratriathlon, and is aiming to be selected for the New Zealand Paralympic team to compete at the 2032 Paralympics. Because of her medical history, and the loss of her mum to cancer 18 months ago, Phoebe said she never took anything for granted. Her mum was not only her mother — she was her eyes and her carer. "So you always make sure you say 'I love you' every day, because you just don't know how long you've got. "Life's too short. You have to make the most of it. "And most importantly, overcoming adversity just makes you stronger — more resilient."
Scoop
3 days ago
- Scoop
Tonga's Health System Hit By Cyberattack
A team of Australian cyber experts flew to Tonga this week after the country's National Health Information System was breached, leading to a demand for payment from the hackers. Talanoa O Tonga reports the Health Minister Dr Ana Akauola saying the system has been shut down, and staff are handling data manually. Dr Akauola said that hackers encrypted the system and demanded payment, but she has assured MPs "the hackers won't damage the information" on the system. This system was introduced in 2019 with Asian Development Bank (ADB) support to digitise Tonga's health records before going "live" in 2021. Police Minister Paula Piukala was critical of past governments for ignoring warnings that Tonga's digital infrastructure is not fully prepared for these threats. Journalist Sifa Pomana said the hackers are demanding millions of dollars, according to Tonga Police. Residents are being urged to bring essential records to the hospital to help with manual record-keeping.
1News
3 days ago
- 1News
Israeli hospital suffers 'extensive damage' from Iranian missile strike
Israel's main southern hospital has sustained a direct hit from an Iranian missile, with officials reporting "extensive damage". The Soroka Medical Centre is the main hospital in Israel's south. A spokesperson for the Soroka Medical Center in Beer Sheba said the hospital suffered 'extensive damage' in different areas and people had been wounded in the attack. The hospital has requested people not come for treatment. The hospital has over 1000 beds and provides services to the approximately 1 million residents of Israel's south, according to the hospital's website. A woman is evacuated from the site of a direct hit from an Iranian missile strike in Ramat Gan, Israel, Thursday, June 19, 2025. (Source: Associated Press) ADVERTISEMENT The strike came as Israel attacked Iran's Arak heavy water reactor, Iranian state television said Thursday. The report said there was 'no radiation danger whatsoever'. An Iranian state television reporter, on live in the nearby town of Khondab, said the facility had been evacuated and there was no damage done to civilian areas around the reactor. Israel had warned earlier Thursday morning it would attack the facility and urged the public to flee the area. The Israeli military said Thursday's round of airstrikes targeted Tehran and other areas of Iran, without elaborating. It later said Iran fired a new salvo of missiles at Israel and told the public to take shelter. Israel's seventh day of airstrikes on Iran came a day after Iran's supreme leader rejected US calls for surrender and warned that any military involvement by the Americans would cause 'irreparable damage to them'. Israel also lifted some restrictions on daily life, suggesting the missile threat from Iran on its territory was easing. Already, Israel's campaign has targeted Iran's enrichment site at Natanz, centrifuge workshops around Tehran and a nuclear site in Isfahan. Its strikes have also killed top generals and nuclear scientists. A Washington-based Iranian human rights group said at least 639 people, including 263 civilians, have been killed in Iran and more than 1,300 wounded. In retaliation, Iran has fired some 400 missiles and hundreds of drones, killing at least 24 people in Israel and wounding hundreds. Some have hit apartment buildings in central Israel, causing heavy damage. ADVERTISEMENT The Arak heavy water reactor is 250 kilometers (155 miles) southwest of Tehran. Heavy water helps cool nuclear reactors, but it produces plutonium as a byproduct that can potentially be used in nuclear weapons. That would provide Iran another path to the bomb beyond enriched uranium, should it choose to pursue the weapon. Iran had agreed under its 2015 nuclear deal with world powers to redesign the facility to relieve proliferation concerns. In 2019, Iran started up the heavy water reactor's secondary circuit, which at the time did not violate Tehran's 2015 nuclear deal with world powers. Britain at the time was helping Iran redesign the Arak reactor to limit the amount of plutonium it produces, stepping in for the US, which had withdrawn from the project after President Donald Trump's decision in 2018 to unilaterally withdraw America from the nuclear deal. The International Atomic Energy Agency, the United Nations' nuclear watchdog, has been urging Israel not to strike Iranian nuclear sites. IAEA inspectors reportedly last visited Arak on May 14. Due to restrictions Iran imposed on inspectors, the IAEA has said it lost 'continuity of knowledge' about Iran's heavy water production -- meaning it could not absolutely verify Tehran's production and stockpile. ADVERTISEMENT As part of negotiations around the 2015 deal, Iran agreed to sell off its heavy water to the West to remain in compliance with the accord's terms. Even the US purchased some 32 tons of heavy water for over $8 million (NZ$13.3 million) in one deal. That was one issue that drew criticism from opponents to the deal.
